DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c8mm88/global_cancer) has announced the addition of the "Global Cancer Vaccines Pipeline Capsule - 2012" report to their offering.
Fore Pharma's latest report 'Global Cancer Vaccines Pipeline Capsule - 2012' provides up-to-date information on key Research and Development activities (R&D) in the global cancer vaccines market. It covers active cancer vaccines pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track their competitor's pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Features of the Report:
- Cancer Vaccines: Overview
- Cancer Vaccines Pipeline Overview
- Cancer Vaccines Phase 3 Clinical Trial Pipeline Insights
- Cancer Vaccines Phase 2 Clinical Trial Pipeline Insights
- Cancer Vaccines Phase 1 Clinical Trial Pipeline Insights
- Cancer Vaccines Preclinical Research Pipeline Insights
- Cancer Vaccines Discovery Stage Pipeline Insights
- Geographic Landscape of Cancer Vaccines R&D Activities
- Cancer Vaccines R&D Activities in North America
- Cancer Vaccines R&D Activities in Europe
- Licensing Activities / Partnerships
- Tables and Figures
For more information visit http://www.researchandmarkets.com/research/c8mm88/global_cancer